160 related articles for article (PubMed ID: 8640868)
1. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
Tamura A; Katsumata M; Greene MI; Yui K
Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
Tamura A; Yui K
J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
4. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
[TBL] [Abstract][Full Text] [Related]
5. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
[TBL] [Abstract][Full Text] [Related]
6. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
Smith KG; Strasser A; Vaux DL
EMBO J; 1996 Oct; 15(19):5167-76. PubMed ID: 8895561
[TBL] [Abstract][Full Text] [Related]
7. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
[TBL] [Abstract][Full Text] [Related]
8. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
Nakajima H; Leonard WJ
J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
[TBL] [Abstract][Full Text] [Related]
9. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
Van Parijs L; Biuckians A; Abbas AK
J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
[TBL] [Abstract][Full Text] [Related]
11. Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract.
Suzuki A; Matsuzawa A; Iguchi T
Oncogene; 1996 Jul; 13(1):31-7. PubMed ID: 8700551
[TBL] [Abstract][Full Text] [Related]
12. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
[TBL] [Abstract][Full Text] [Related]
13. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
[TBL] [Abstract][Full Text] [Related]
14. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
Kronin V; Winkel K; Süss G; Kelso A; Heath W; Kirberg J; von Boehmer H; Shortman K
J Immunol; 1996 Nov; 157(9):3819-27. PubMed ID: 8892611
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.
Suda T; Tanaka M; Miwa K; Nagata S
J Immunol; 1996 Nov; 157(9):3918-24. PubMed ID: 8892623
[TBL] [Abstract][Full Text] [Related]
18. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
Aggarwal S; Gupta S
J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
[TBL] [Abstract][Full Text] [Related]
20. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
